Disorders of Blood Flow: Hyperlipidemia, Atherosclerosis, Arterial and Venous Disorders

Study Guide - Smart Notes

Tailored notes based on your materials, expanded with key definitions, examples, and context.

Disorders of Blood Flow

Introduction

Disorders of blood flow encompass a range of pathological conditions affecting the arteries and veins, including hyperlipidemia, atherosclerosis, arterial diseases, and venous disorders. These conditions are central to cardiovascular health and are commonly encountered in clinical practice.

Hyperlipidemia & Atherosclerosis

Cholesterol and Triglyceride Laboratory Values

Cholesterol and triglyceride levels are key indicators of lipid metabolism and cardiovascular risk. Laboratory measurement of these values is essential for diagnosis and management.

Cholesterol (mg/dL)	Classification
0-199	Optimal
200-239	Borderline high
≥240	High

LDL (mg/dL)	Classification
0-99	Optimal
100-129	Above optimal
130-159	Borderline high
160-189	High
≥190	Very high

HDL (mg/dL)	Classification
<40	Low
≥60	High ("good cholesterol")

Triglycerides (mg/dL)	Classification
0-149	Normal
150-199	Borderline high
200-499	High
≥500	Very high

Lipid Laboratory Measurement

Fasting State: Lipid panels are ideally measured after 12 hours of fasting to clear chylomicrons and IDL from the blood.
Non-fasting State: Only total cholesterol and HDL are considered accurate; LDL is commonly calculated.
LDL Calculation:
VLDL Approximation: VLDL is estimated by dividing triglycerides by 5.

Atherosclerosis Risk Factors

Atherosclerosis is a chronic inflammatory disease of the arterial wall, driven by lipid accumulation and endothelial dysfunction. Risk factors are classified as modifiable (secondary) and non-modifiable (primary).

Modifiable (Secondary)	Mechanism
Hypercholesterolemia (e.g., diet)	↑LDL: Substrate for plaque; ↓HDL: Cholesterol removal from circulation
Obesity	Proinflammatory cytokine release from adipose tissue
Hypertension (HTN)	Shear stress/damage to endothelium
Diabetes	↓LDL removal from circulation, glycation of lipoproteins
Cigarette smoking	Endothelial damage
Hypothyroidism	↓LDL receptor production
Lipoprotein A/homocysteine	↑Oxidation of LDL

Non-modifiable (Primary)	Mechanism
Male gender	Estrogen ↑ LDL receptors (protective in females)
Genetic factors	Inherited lipid metabolism disorders

Hyperlipidemia Disorders

Primary (Genetic): Familial hypercholesterolemia (Type IIa) is the most common, due to LDL receptor dysfunction, leading to impaired hepatic LDL uptake and elimination. Heterozygotes present with cholesterol 250-500 mg/dL and earlier clinical manifestations; homozygotes (rare) may have cholesterol up to 1000 mg/dL and childhood onset.
Secondary: Caused by high-fat or high-carbohydrate diets, medications (beta-blockers, glucocorticoids, antipsychotics, estrogen/progestin), obesity, diabetes mellitus, hypothyroidism, nephrotic syndrome, and liver disease.

Clinical Manifestations of Hyperlipidemia

Pancreatitis: Associated with hypertriglyceridemia.
Atherosclerosis: Can affect coronary arteries (acute coronary syndromes), carotid/cerebral arteries (ischemic stroke), aorta (aneurysms), lower extremities (peripheral arterial disease), mesenteric and renal arteries (kidney disease).

Treatment of Hyperlipidemia

Lifestyle Modifications: Limit saturated fats, increase physical activity.
Drug Therapy:
- Statins: Block cholesterol synthesis.
- Bile Acid Resins: Bind cholesterol-containing bile acids in the gut.
- Niacin: Blocks VLDL synthesis, lowers LDL.
- Fibrates: Block VLDL synthesis, increase triglyceride clearance.
- Ezetimibe: Blocks intestinal cholesterol absorption.
- Lomitapide: Blocks VLDL synthesis.
- PCSK9 inhibitors: Block LDL receptor degradation in hepatocytes.

Arterial Disorders

Peripheral Artery Disease (PAD)

PAD is a manifestation of systemic atherosclerosis, most commonly affecting the femoral and popliteal arteries. Risk increases with age and comorbidities.

Clinical Presentation: Often asymptomatic until significant occlusion. Symptoms include ischemic pain/discomfort/fatigue with exertion (intermittent claudication), pain at rest (advanced disease), ulcerations, necrosis, gangrene, thinning skin, muscle wasting, and weak or absent pedal/popliteal pulses.
Diagnosis: Clinical assessment plus blood pressure measurement of brachial and tibial (ankle) arteries. Ankle:Brachial Index (ABI) < 0.9 is consistent with vascular occlusion. Sensitivity and specificity > 90%.
Treatment: Lifestyle modifications, exercise (walking 30-45 min, 3x/week), risk factor management, antiplatelet agents (aspirin is first-line), clopidogrel, dipyridamole, cilostazol (inhibits platelet aggregation and causes vasodilation).

Aneurysms and Dissections

Aneurysms are localized dilations of blood vessels (arteries >> veins), often due to atherosclerosis, hypertension, congenital abnormalities, trauma, or infection. Dissections involve tearing of the vascular wall, most commonly in the ascending aorta.

Types of Aneurysms:
- Berry: Small, saccular aneurysms, often in cerebral arteries.
- Fusiform: Full circumference dilation of vessel.
- Saccular: Outpouching of vessel wall.
- Dissection: Hemorrhage between intima and media layers.
Aortic Aneurysms: Thoracic (10%) and abdominal (90%, usually below renal arteries). Symptoms include pain, pulsating abdominal mass, thrombus formation, and distal emboli. Rupture is life-threatening; risk increases with diameter (<4cm: 2%, >5cm: 10%). Treatment is surgical repair.
Aortic Dissection: Sudden onset of intense pain (anterior chest for ascending, back for descending), possible paralysis, syncope, heart failure, limb ischemia. Treatment includes blood pressure control (beta-blockers, nitroprusside) and surgical resection with graft.

Venous Disorders

Venous Thromboembolism (VTE)

VTE includes deep vein thrombosis (DVT) and pulmonary embolism (PE). Thrombus formation and embolism are most common in lower extremities, especially around vein valves.

Superficial Veins: Lower risk of thrombosis and PE.
Deep Veins: Significant risk of PE and chronic venous insufficiency.

Venous Thrombosis Risk Factors (Virchow’s Triad)

Category	Examples
Stasis (low blood flow)	Immobility (>3 days), heart failure, shock, dehydration, obesity, venous catheterization
Hypercoagulability	Cancer, antiphospholipid syndrome, inherited clotting factor mutations (Factor V Leiden, protein C & S, antithrombin), oral contraceptives/hormone replacement
Vascular Trauma	Major trauma/fracture, surgery (especially orthopedic), caesarean section, cardiac pacemaker placement, venous catheterization

Pathophysiology of Venous Thromboembolism

Risk factors initiate inflammation and platelet binding to vascular endothelium.
Tissue factor expression on leukocytes stimulates coagulation.
Thrombus forms around neutrophil extracellular traps (NETs).

Clinical Manifestations of DVT

Often asymptomatic, especially isolated calf DVT.
Symptoms: Unilateral pain/tenderness, swelling, inflammatory signs.
Laboratory: Elevated WBC, D-dimer.
Complications: Pulmonary embolism.

Laboratory Assessment

D-dimer: Degradation product of cross-linked fibrin. <500 ng/mL considered negative (high sensitivity); >500 ng/mL requires further testing for VTE.

Prevention and Treatment of DVT

Prevention: Risk factor assessment, mobility, pneumatic compression devices, compression stockings, prophylactic anticoagulation (low-dose heparin, low molecular weight heparin).
Treatment: Thrombolytic therapy (tPA for emergent cases), anticoagulant therapy (warfarin, low molecular weight heparin, direct factor Xa inhibitors such as apixaban, rivaroxaban, edoxaban, fondaparinux).

Chronic Venous Disease

Pathophysiology and Risk Factors

Chronic venous disease is characterized by increased venous pressure, especially in the lower extremities due to gravity, compromised venous return, and inflammation. Venous wall remodeling leads to thickened and dilated veins.

Risk Factors: Age (>50 years), female gender, obesity, sedentary lifestyle, prolonged sitting/standing, smoking, family history (congenital valve incompetence), height.

Clinical Manifestations

Progressive disease: Varicose veins, lower limb edema, discomfort, skin changes (lipodermatosclerosis, stasis dermatitis), brown pigmentation (RBC breakdown/hemosiderin), venous ulcers (80% of cases).
Pathophysiology: Endothelial permeability, leukocyte and RBC extravasation, fibrin and hemosiderin deposition, proinflammatory cytokine release, collagen synthesis, vascular wall thickening, decreased elastin synthesis.

Varicose Veins

Dilated, tortuous (twisty) saphenous and deep veins of the lower extremities.
Inability to adequately return blood to the heart due to valve dysfunction and impaired muscle pump action.
Clinical features: Visible, twisted veins, heaviness, aching, edema, and increased risk of chronic venous insufficiency.

Chronic Venous Insufficiency

Dilated veins (varicose veins), tissue edema, leg pain/discomfort, heaviness/aching, tenderness along varicosities, intermittent claudication (pain during ambulation with deep vein involvement).
Cutaneous changes: Lipodermatosclerosis (fibrotic hardening of skin), brown pigmentation, stasis dermatitis, venous ulcers.